Test designed to screen resistance to cancer drug
Thursday, July 29, 2010 - 5:17AM
HONG KONG (Reuters) - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.
Featured Product
Subscribe to our Newsletter
Subscribe to our free email newsletter
Your email address will be kept totally secure and will only be used to send you our newsletter.
Connect With Us
Megavista Health on Facebook
